CANNABISOLVE

CannabiSolve™ provides technology and services towards accelerating drug development using an integrative platform for quantitative modeling of complex molecular pathways. The platform uses in-silico modeling to bridge in-vitro testing with human clinical trials with the goal of eliminating animal experimentation. CannabiSolve™ is built on the foundation of Computational biology, a field that is in rapid transition from diagrammatic representation of pathways to quantitative and predictive mathematical models, which span time-scales, knowledge domains and spatial-scales. This transition is being accelerated by high-throughput experimentation which isolates reactions and their corresponding rate constants... CannabiSolve, Inc. was founded in 2011 Dr. VA Shiva Ayyadurai, Ph.D., an MIT systems scientist, the inventor of email and creator of EchoMail. CannabiSolve has developed the world's first computational platform for scalable integration of molecular pathway models. The platform..

Also known as: CannabiSolve, Inc.

Primary location: Cambridge United States